A detailed history of Ci Private Wealth, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Ci Private Wealth, LLC holds 159,447 shares of ESPR stock, worth $357,161. This represents 0.0% of its overall portfolio holdings.

Number of Shares
159,447
Previous 182,500 12.63%
Holding current value
$357,161
Previous $405,000 35.06%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.61 - $2.73 $37,115 - $62,934
-23,053 Reduced 12.63%
159,447 $263,000
Q2 2024

Aug 13, 2024

BUY
$1.84 - $3.24 $335,800 - $591,300
182,500 New
182,500 $405,000
Q1 2023

May 15, 2023

BUY
$1.46 - $7.3 $25,307 - $126,538
17,334 New
17,334 $27,000

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $149M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Ci Private Wealth, LLC Portfolio

Follow Ci Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.